We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Record of the discussion that took place at SAGE's ninety-second meeting.
Information on how the 2019 voluntary scheme for branded medicines pricing and access is controlling spend on branded medicines in the NHS.
Latest epidemiological data used by the government to brief MPs on the roadmap out of lockdown and to inform local and national decision-making in response to COVID-19 outbreaks.
Data for the coverage of wastewater testing in England as part of the Environmental Monitoring for Health Protection (EMHP) programme.
Experimental statistics on NHS Test and Trace since its launch on 28 May 2020. Includes reports on NHS Test and Trace (people tested and contact tracing) and rapid (lateral flow device) testing for people without symptoms.
Annual review of the activities and achievements of the Independent Reconfiguration Panel (IRP) from April 2020 to March 2021.
Weekly watchlist giving epidemiological coronavirus (COVID-19) data for each lower-tier local authority (LTLA) in England.
A summary of key data used by the Joint Biosecurity Centre (JBC) to inform country risk assessments.
This report sets out how G7 countries led on improving global health and tackling epidemics and emerging threats since 2015, including in the COVID-19 pandemic.
First published during the 2019 to 2022 Johnson Conservative government
Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 5 April 2021
Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 26 April 2021
Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 19 April 2021
Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 12 April 2021
The seventh two-monthly report on which powers in the Coronavirus Act 2020 are currently active.
Annual report from the MHRA on the regulation of medicines advertising to promote transparency.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).